ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.

Nitin Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.